An open label , drug drug interaction study to determine the pharmacokinetics (PK), pharmacodynamics (PD), and safety of INCB057643 and warfarin in healthy volunteers.
Latest Information Update: 06 May 2019
At a glance
- Drugs INCB 057643 (Primary) ; Warfarin (Primary)
- Indications Cancer
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
Most Recent Events
- 06 May 2019 New trial record
- 16 Mar 2019 Results presented at the 120th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics